133 results on '"Iwasa Motoh"'
Search Results
2. Serum Zinc-α2-glycoprotein Levels Are Associated with the Hepatorenal Function and Predict the Survival in Cases of Chronic Liver Disease
3. Circulating extracellular vesicles are associated with pathophysiological condition including metabolic syndrome-related dysmetabolism in children and adolescents with obesity
4. Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma
5. Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab
6. Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
7. Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets
8. Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study
9. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment
10. Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans
11. Complement complex 1 subunit q‐mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases
12. Author response: Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans
13. Risk factors for portopulmonary hypertension in patients with cirrhosis: A prospective, multicenter study
14. The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage
15. Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease
16. Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function
17. Development of a New Index to Distinguish Hepatic Encephalopathy through Automated Quantification of Globus Pallidal Signal Intensity Using MRI
18. Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in chronic liver disease rats and humans.
19. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
20. Successful endoscopic cyanoacrylate injection therapy for ruptured duodenal varices immediately after balloon‐occluded retrograde transvenous obliteration
21. Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites
22. Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
23. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound‐fine needle aspiration samples contain a protein barcode
24. Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
25. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
26. A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C
27. Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan
28. Protein Composition of Circulating Extracellular Vesicles Immediately Changed by Particular Short Time of High-Intensity Interval Training Exercise
29. Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
30. Plexin domain containing protein 2 is more expressed within the invasive area of human colorectal cancer tissues
31. Branched-chain amino acids protect the liver from cirrhotic injury via suppression of activation of lipopolysaccharide-binding protein, toll-like receptor 4, and signal transducer and activator of transcription 3, as well as Enterococcus faecalis translocation
32. Accuracy of carbohydrate‐deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism
33. Proposal of Stroop test cut‐off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study
34. A Rare Presentation of Intraperitoneal Ectopic Varices Rupture
35. Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver
36. The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases
37. Serum copeptin and zinc-α2-glycoprotein levels are novel biomarkers of tolvaptan treatment in decompensated cirrhotic patients with ascites.
38. Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease
39. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
40. The efficacy of serum copeptin and zinc-alpha2-glycoprotein for predictors of tolvaptan treatment in decompensated cirrhotic patients
41. Analysis of factors associated with the prognosis of cirrhotic patients who were treated with V2-receptor antagonist for hepatic edema
42. The effects of diuretic use and the presence of ascites on muscle cramps in patients with cirrhosis: a nationwide study
43. Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma
44. Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema
45. Clinical features of liver cirrhosis patients with muscle cramping: a multicenter study
46. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
47. Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus‐related liver cirrhosis
48. Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains
49. Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma
50. Circulating Extracellular Vesicles and Their miR “Barcode” Differentiate Alcohol Drinkers With Liver Injury and Those Without Liver Injury in Severe Trauma Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.